Term: evaluable patients Pronunciation: (ee-VAL-yoo-uh-bul PAY-shunts) May 24, 2024October 7, 2025 Description: Patients whose response to a treatment can be measured because enough information has been collected. Related Posts:The Bruton’s Tyrosine Kinase (BTK) Inhibitor…TAFINLAR® and MEKINIST® (Dabrafenib and Trametinib)…PERJETA® (Pertuzumab) The FDA on September 30, 2013…Aggressive Melanoma in patients with CLLFDA Approves VENCLEXTA® for Elderly Patients with AMLPlatelet Antibody Testing in Patients with ITP